BCLS II Investco, LP
Related Filers (14)
- BCLS II Investco (GP), LLC (5)
- Bain Capital Life Sciences Fund II, L.P. (5)
- Bain Capital Life Sciences Investors II, LLC (5)
- Bain Capital Life Sciences Investors, LLC (5)
- BCIP Life Sciences Associates, LP (5)
- NewAmsterdam Pharma Co N.V. (3)
- Xilio Therapeutics, Inc. (2)
- Bain Capital Life Sciences Partners, LP (2)
- BCLS SB Investco, LP (2)
- Solid Biosciences Inc. (2)
- BCLS Fund III Investments GP, LLC (1)
- BCLS Fund III Investments, LP (1)
- Bain Capital Life Sciences Fund III, L.P. (1)
- Bain Capital Life Sciences III General Partner, LLC (1)
- Show More ...
Other (5)
13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (7)
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/29/2023
NewAmsterdam Pharma Co N.V.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 6/13/2023
NewAmsterdam Pharma Co N.V.: Major Shareholders
3
Monday, 12/5/2022
Solid Biosciences Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 12/2/2022
NewAmsterdam Pharma Co N.V.: Major Shareholders
4
Friday, 12/10/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities